American Cancer Society Head and Neck Cancer Survivorship Care Guideline

CA Cancer Journal for Clinicians

Volumn 66, Issue 3, 2016, Pages 203-239

  Cohen, Ezra E W ^a   Lamonte, Samuel J ^b   Erb, Nicole L ^c   Beckman, Kerry L ^c   Sadeghi, Nader ^d   Hutcheson, Katherine A ^e   Stubblefield, Michael D ^f   Abbott, Dennis M ^g   Fisher, Penelope S ^h   Stein, Kevin D ⁱ   Lyman, Gary H ^j   Pratt Chapman, Mandi L ^d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f KESSLER INSTITUTE FOR REHABILITATION   (United States)

^g Kessler Institute for Rehabilitation ^*  (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ BEHAVIORAL RESEARCH CENTER   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

care coordination; clinical follow up care; guidelines; head and neck cancer; late effects; long term effects; primary care; quality of life; survivorship; survivorship care plan

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CHLORHEXIDINE GLUCONATE; DULOXETINE; ERYTHROMYCIN; GABAPENTIN; PREGABALIN;

AGEUSIA; ASPIRATION; BONE NECROSIS; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CERVICAL DYSTONIA; CLINICAL FEATURE; COGNITIVE BEHAVIORAL THERAPY; DENTAL CARIES; DIET THERAPY; DOCTOR PATIENT RELATION; DYSPHAGIA; ESOPHAGUS DILATATION; ESOPHAGUS METASTASIS; ESOPHAGUS STENOSIS; FATIGUE; GASTROESOPHAGEAL REFLUX; HEAD AND NECK CANCER; HEALTH PROMOTION; HEARING AID; HEARING IMPAIRMENT; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; INTERPERSONAL COMMUNICATION; LONG TERM CARE; LUNG METASTASIS; MEDICAL HISTORY; MENTAL DISEASE; MOUTH HYGIENE; MOUTH INFECTION; MUSCLE SPASM; MYALGIA; NERVE PARALYSIS; NEUROPATHY; NUTRITION; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PERIODONTITIS; PHYSICAL ACTIVITY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SELF CONCEPT; SHOULDER DISEASE; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SPEECH DISORDER; SPEECH THERAPY; SPINAL ACCESSORY NERVE PALSY; TRISMUS; VERTIGO; XEROSTOMIA; ACCESSORY NERVE DISEASES; AFTERCARE; ANXIETY; BURSITIS; DEGLUTITION DISORDERS; DENTAL PROCEDURE; DEPRESSION; DISEASE MANAGEMENT; DYSTONIA; HEAD AND NECK NEOPLASMS; LYMPHEDEMA; MENTAL STRESS; NECK MUSCLE; NON PROFIT ORGANIZATION; OSTEONECROSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOLOGY; RESPIRATORY ASPIRATION; SLEEP APNEA SYNDROMES; SLEEP WAKE DISORDERS; SURVIVOR; TASTE DISORDERS; VESTIBULAR NEURONITIS; VOICE DISORDERS;

ACCESSORY NERVE DISEASES; AFTERCARE; AMERICAN CANCER SOCIETY; ANXIETY; BURSITIS; DEGLUTITION DISORDERS; DENTAL CARE; DENTAL CARIES; DEPRESSION; DISEASE MANAGEMENT; DYSTONIA; FATIGUE; GASTROESOPHAGEAL REFLUX; HEAD AND NECK NEOPLASMS; HEALTH PROMOTION; HUMANS; HYPOTHYROIDISM; LYMPHEDEMA; NECK MUSCLES; OSTEONECROSIS; PERIODONTITIS; PERIPHERAL NERVOUS SYSTEM DISEASES; RESPIRATORY ASPIRATION; SLEEP APNEA SYNDROMES; SLEEP WAKE DISORDERS; STRESS, PSYCHOLOGICAL; SURVIVORS; TASTE DISORDERS; TRISMUS; VESTIBULAR NEURONITIS; VOICE DISORDERS; XEROSTOMIA;

EID: 84965144857     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21343     Document Type: Review

References (184)

1. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66: 7-30.
2. DeSantis CE, Lin CC, Mariotto AB, et al., Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252-271.
3. Ganz PA,. Survivorship: adult cancer survivors. Primary Care. 2009; 36: 721-741.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2013; 100 (pt E): 1-538.
5. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
6. Blot WJ, McLaughlin JK, Winn DM, et al., Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988; 48: 3282-3287.
7. Young D, Xiao CC, Murphy B, Moore M, Fakhry C, Day TA,. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015; 51: 727-730.
8. Seiwert TY, Zuo Z, Keck MK, et al., Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015; 21: 632-641.
9. Chung CH, Bagheri A, D'Souza G,. Epidemiology of oral human papillomavirus infection. Oral Oncol. 2014; 50: 364-369.
10. Pfister D, et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Head and Neck Cancers. V.1.2015. © National Comprehensive Cancer Network, Inc 2015. All rights reserved. Available at NCCN.org. Accessed January 27, 2016.
11. Benson E, Li R, Eisele D, Fakhry C,. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014; 50: 565-574.
12. Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press; 2005.
13. Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, et al., Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin. 2013; 63: 147-150.
14. ®) for Lung Cancer Screening. V.1.2016. © National Comprehensive Cancer Network, Inc 2015. All rights reserved. Available at NCCN.org. Accessed January 27, 2016.
15. Brawley O, Byers T, Chen A, et al., New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011; 306: 2495-2499.
16. Skolarus TA, Wolf AM, Erb NL, et al., American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014; 64: 225-249.
17. Hershman DL, Lacchetti C, Dworkin RH, et al., Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014; 32: 1941-1967.
18. Andersen BL, Rowland JH, Somerfield MR,. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2015; 11: 133-134.
19. Bower JE, Bak K, Berger A, et al., Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol. 2014; 32: 1840-1850.
20. Denlinger CS, et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship. V.2.2015. © National Comprehensive Cancer Network, Inc 2015. All rights reserved. Available at NCCN.org. Accessed January 27, 2016.
21. Holland JC, et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Distress Management. V.3.2015. © National Comprehensive Cancer Network, Inc 2015. All rights reserved. Available at NCCN.org. Accessed January 27, 2016.
22. Helfand M, Carson S,. Screening for Lipid Disorders in Adults: Selective Update of 2001 US Preventive Services Task Force Review. Report No. 09-05114-EF-1. Rockville, MD: Agency for Healthcare Research and Quality (US); 2008.
23. Manikantan K, Khode S, Dwivedi RC, et al., Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev. 2009; 35: 744-753.
24. Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE,. Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance. Laryngoscope. 2009; 119: 2135-2140.
25. Morton RP, Hay KD, Macann A,. On completion of curative treatment of head and neck cancer: why follow up? Otolaryngol Head Neck. 2004; 12: 142-146.
26. Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I,. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Cause Control. 2011; 22: 671-679.
27. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I,. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011; 29: 739-746.
28. Atienza JA, Dasanu CA,. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin. 2012; 28: 1899-1909.
29. Rennemo E, Zatterstrom U, Boysen M,. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008; 118: 1350-1356.
30. Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB,. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014; 120: 1507-1513.
31. Jayaprakash V, Cheng C, Reid M, et al., Previous head and neck cancers portend poor prognoses in lung cancer patients. Ann Thorac Surg. 2011; 92: 1056-1060; discussion 1060-1051.
32. National Lung Screening Trial Research Team, Church TR, Black WC, et al., Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013; 368: 1980-1991.
33. Bach PB, Mirkin JN, Oliver TK, et al., Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307: 2418-2429.
34. Farwell DG, Rees CJ, Mouadeb DA, et al., Esophageal pathology in patients after treatment for head and neck cancer. Otolaryngol Head Neck Surg. 2010; 143: 375-378.
35. Umeda M, Shigeta T, Takahashi H, et al., Shoulder mobility after spinal accessory nerve-sparing modified radical neck dissection in oral cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109: 820-824.
36. Erisen L, Basel B, Irdesel J, et al., Shoulder function after accessory nerve-sparing neck dissections. Head Neck. 2004; 26: 967-971.
37. Carr SD, Bowyer D, Cox G,. Upper limb dysfunction following selective neck dissection: a retrospective questionnaire study. Head Neck. 2009; 31: 789-792.
38. Stubblefield MD,. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R. 2011; 3: 1041-1054.
39. Peng G, Wang T, Yang KY, et al., A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012; 104: 286-293.
40. Tuan JK, Ha TC, Ong WS, et al., Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiother Oncol. 2012; 104: 305-311.
41. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS,. Gabapentin for chronic neuropathic pain and fibromyalgia in adults [serial online]. Cochrane Database Syst Rev. 2014; 4: CD007938.
42. Gaskell H, Moore RA, Derry S, Stannard C,. Oxycodone for neuropathic pain and fibromyalgia in adults [serial online]. Cochrane Database Syst Rev. 2014; 6: CD010692.
43. Stubblefield MD, Levine A, Custodio CM, Fitzpatrick T,. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Arch Phys Med Rehabil. 2008; 89: 417-421.
44. Stubblefield MD, Manfield L, Riedel ER,. A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer. Arch Phys Med Rehabil. 2010; 91: 1278-1282.
45. Bach CA, Wagner I, Lachiver X, Baujat B, Chabolle F,. Botulinum toxin in the treatment of post-radiosurgical neck contracture in head and neck cancer: a novel approach. Eur Ann Otorhinolaryngol Head Neck Dis. 2012; 129: 6-10.
46. Trignano E, Dessy LA, Fallico N, et al., Treatment of pectoralis major flap myospasms with botulinum toxin type A in head and neck reconstruction [serial online]. J Plast Reconst Aesthet Surg. 2012; 65: e23-e28.
47. Wittekindt C, Liu WC, Preuss SF, Guntinas-Lichius O,. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study. Laryngoscope. 2006; 116: 1168-1171.
48. Dijkstra PU, van Wilgen PC, Buijs RP, et al., Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors. Head Neck. 2001; 23: 947-953.
49. Stubblefield MD,. Cancer rehabilitation. Semin Oncol. 2011; 38: 386-393.
50. McNeely ML, Parliament M, Courneya KS, et al., A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck. 2004; 26: 518-530.
51. McNeely ML, Parliament MB, Seikaly H, et al., Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer. 2008; 113: 214-222.
52. Lauchlan DT, McCaul JA, McCarron T, Patil S, McManners J, McGarva J,. An exploratory trial of preventative rehabilitation on shoulder disability and quality of life in patients following neck dissection surgery. Eur J Cancer Care. 2011; 20: 113-122.
53. Carvalho AP, Vital FM, Soares BG,. Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer [serial online]. Cochrane Database Syst Rev. 2012; 4: CD008693.
54. Uppal HS, Evans JP, Smith C,. Frozen shoulder: a systematic review of therapeutic options. World J Orthop. 2015; 6: 263-268.
55. Noten S, Meeus M, Stassijns G, Van Glabbeek F, Verborgt O, Struyf F,. The efficacy of different types of mobilization techniques in patients with primary adhesive capsulitis of the shoulder: a systematic review [published online ahead of print 2015]. Arch Phys Med Rehabil. 2015. doi: 10.1016/j.apmr.2015.07.025.
56. Gerber LH, Shah J, Rosenberger W, et al., Dry needling alters trigger points in the upper trapezius muscle and reduces pain in subjects with chronic myofascial pain. PM R. 2015; 7: 711-718.
57. Dijkstra PU, Huisman PM, Roodenburg JL,. Criteria for trismus in head and neck oncology. Int J Oral Max Surg. 2006; 35: 337-342.
58. Stubblefield MD, Keole N,. Upper body pain and functional disorders in patients with breast cancer. PM R. 2014; 6: 170-183.
59. Louise Kent M, Brennan MT, Noll JL, et al., Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008; 16: 305-309.
60. Pauli N, Johnson J, Finizia C, Andrell P,. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncol. 2013; 52: 1137-1145.
61. Weber C, Dommerich S, Pau HW, Kramp B,. Limited mouth opening after primary therapy of head and neck cancer. J Oral Maxillofac Surg. 2010; 14: 169-173.
62. Scott B, Butterworth C, Lowe D, Rogers SN,. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol. 2008; 44: 430-438.
63. Dijkstra PU, Sterken MW, Pater R, Spijkervet FK, Roodenburg JL,. Exercise therapy for trismus in head and neck cancer. Oral Oncol. 2007; 43: 389-394.
64. Tang Y, Shen Q, Wang Y, Lu K, Wang Y, Peng Y,. A randomized prospective study of rehabilitation therapy in the treatment of radiation-induced dysphagia and trismus. Strahlenther Onkol. 2011; 187: 39-44.
65. Chua DT, Lo C, Yuen J, Foo YC,. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol. 2001; 24: 366-369.
66. Hartl DM, Cohen M, Julieron M, Marandas P, Janot F, Bourhis J,. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck. 2008; 138: 459-463.
67. Francis DO, Weymuller EA Jr, Parvathaneni U, Merati AL, Yueh B,. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? Ann Otol Rhinol Larynol. 2010; 119: 391-397.
68. Crary MA, Carnaby GD, LaGorio LA, Carvajal PJ,. Functional and physiological outcomes from an exercise-based dysphagia therapy: a pilot investigation of the McNeill Dysphagia Therapy Program. Arch Phys Med Rehab. 2012; 93: 1173-1178.
69. Lan Y, Ohkubo M, Berretin-Felix G, Sia I, Carnaby-Mann GD, Crary MA,. Normalization of temporal aspects of swallowing physiology after the McNeill dysphagia therapy program. Ann Otol Rhinol Larynol. 2012; 121: 525-532.
70. Crary MA, Carnaby Mann GD, Groher ME, Helseth E,. Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback. Dysphagia. 2004; 19: 160-164.
71. Oliver LJ, Keeton M, Wilson EL,. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562). Blood. 1989; 74: 1321-1327.
72. Eisbruch A, Lyden T, Bradford CR, et al., Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 23-28.
73. Hutcheson KA, Lewin JS, Holsinger FC, et al., Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck. 2014; 36: 474-480.
74. Hunter KU, Lee OE, Lyden TH, et al., Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head Neck. 2014; 36: 120-125.
75. Murphy BA, Gilbert J,. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009; 19: 35-42.
76. Cousins N, MacAulay F, Lang H, MacGillivray S, Wells M,. A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol. 2013; 49: 387-400.
77. McCabe D, Ashford J, Wheeler-Hegland K, et al., Evidence-based systematic review: oropharyngeal dysphagia behavioral treatments. Part IV-impact of dysphagia treatment on individuals' postcancer treatments. J Rehabil Res Dev. 2009; 46: 205-214.
78. Wang JJ, Goldsmith TA, Holman AS, Cianchetti M, Chan AW,. Pharyngoesophageal stricture after treatment for head and neck cancer. Head Neck. 2012; 34: 967-973.
79. Sweeny L, Golden JB, White HN, Magnuson JS, Carroll WR, Rosenthal EL,. Incidence and outcomes of stricture formation postlaryngectomy. Otolaryngol Head Neck. 2012; 146: 395-402.
80. Deng J, Ridner SH, Murphy BA,. Lymphedema in patients with head and neck cancer [serial online]. Oncol Nurs Forum. 2011; 38: E1-E10.
81. Deng J, Ridner SH, Dietrich MS, et al., Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage. 2012; 43: 244-252.
82. Deng J, Murphy BA, Dietrich MS, et al., Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck. 2013; 35: 1026-1035.
83. Deng J, Ridner SH, Dietrich MS, et al., Factors associated with external and internal lymphedema in patients with head-and-neck cancer [serial online]. Int J Radiat Oncol Biol Phys. 2012; 84: e319-e328.
84. Piso DU, Eckardt A, Liebermann A, Gutenbrunner C, Schafer P, Gehrke A,. Early rehabilitation of head-neck edema after curative surgery for orofacial tumors. Am J Phys Med Rehabil. 2001; 80: 261-269.
85. Smith BG, Hutcheson KA, Little LG, et al., Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck. 2015; 152: 284-291.
86. Bower JE,. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11: 597-609.
87. Rock CL, Doyle C, Demark-Wahnefried W, et al., Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62: 243-274.
88. Gielissen MF, Verhagen CA, Bleijenberg G,. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer. 2007; 97: 612-618.
89. Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK,. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors-a meta-analysis. Psychooncology. 2011; 20: 115-126.
90. Berger A, et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cancer-Related Fatigue. V.1.2016. © National Comprehensive Cancer Network, Inc 2015. All rights reserved. Available at NCCN.org. Accessed January 27, 2016.
91. Rosenthal DI, Mendoza TR, Fuller CD, et al., Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014; 120: 1975-1984.
92. Baharvand M, ShoalehSaadi N, Barakian R, Moghaddam EJ,. Taste alteration and impact on quality of life after head and neck radiotherapy. J Oral Pathol Med. 2013; 42: 106-112.
93. Mossman KL,. Gustatory tissue injury in man: radiation dose response relationships and mechanisms of taste loss. Br J Cancer Suppl. 1986; 7: 9-11.
94. Fernando IN, Patel T, Billingham L, et al., The effect of head and neck irradiation on taste dysfunction: a prospective study. Clin Oncol (R Coll Radiol). 1995; 7: 173-178.
95. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC,. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2009; 73: 779-788.
96. Theunissen EA, Zuur CL, Bosma SC, et al., Long-term hearing loss after chemoradiation in patients with head and neck cancer. Laryngoscope. 2014; 124: 2720-2725.
97. Hutcheson KA, Lewis CM,. Head and neck cancer survivorship management. In:, Foxhall LE, Rodriguez MA, eds. Advances in Cancer Survivorship Management. Part II: Surveillance. MD Anderson Cancer Care Series. New York: Springer; 2015: 145-166.
98. Lonsbury-Martin BL, Martin GK,. Evoked otoacoustic emissions as objective screeners for ototoxicity. Semin Hear. 2001; 22: 377-392.
99. Fausti S,. Audiologic monitoring for ototoxicity and patient management. In:, Campbell KC, ed. Pharmacology and Ototoxicity for Audiologists. Clifton Park, NY: Thomas Delmar Learning; 2006: 230-251.
100. Zhou J, Jolly S,. Obstructive sleep apnea and fatigue in head and neck cancer patients. Am J Clin Oncol. 2015; 38: 411-414.
101. van der Molen L, van Rossum MA, Jacobi I, et al., Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners and patient's perception [serial online]. J Voice. 2012; 26: 664.e625-e633.
102. Luk YS, Shum JS, Sze HC, Chan LL, Ng WT, Lee AW,. Predictive factors and radiological features of radiation-induced cranial nerve palsy in patients with nasopharyngeal carcinoma following radical radiotherapy. Oral Oncol. 2013; 49: 49-54.
103. Awan MJ, Mohamed AS, Lewin JS, et al., Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014; 50: 746-752.
104. Tuomi L, Andrell P, Finizia C,. Effects of voice rehabilitation after radiation therapy for laryngeal cancer: a randomized controlled study. Int J Radiat Oncol Biol Phys. 2014; 89: 964-972.
105. van Gogh CD, Verdonck-de Leeuw IM, Langendijk JA, Kuik DJ, Mahieu HF,. Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer. J Voice. 2012; 26: 398-401.
106. Xi S,. Effectiveness of voice rehabilitation on vocalisation in postlaryngectomy patients: a systematic review. Int J Evid Based Healthc. 2010; 8: 256-258.
107. Marunick M, Tselios N,. The efficacy of palatal augmentation prostheses for speech and swallowing in patients undergoing glossectomy: a review of the literature. J Prosthet Dent. 2004; 91: 67-74.
108. Tell R, Lundell G, Nilsson B, Sjodin H, Lewin F, Lewensohn R,. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004; 60: 395-400.
109. Miller MC, Agrawal A,. Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. Curr Opin Otolaryngol. 2009; 17: 111-115.
110. Smith GL, Smith BD, Garden AS, et al., Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study. Head Neck. 2009; 31: 1031-1038.
111. Epstein JB, Thariat J, Bensadoun RJ, et al., Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012; 62: 400-422.
112. Epstein JB, Guneri P, Barasch A,. Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time. Support Care Cancer. 2014; 22: 1981-1988.
113. Bar Ad V, Weinstein G, Dutta PR, et al., Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy. Cancer. 2010; 116: 4206-4213.
114. Kumar S, Ram S, Navazesh M,. Salivary gland and associated complications in head and neck cancer therapy. J Calif Dent Assoc. 2011; 39: 639-647.
115. Duke RL, Campbell BH, Indresano AT, et al., Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope. 2005; 115: 678-683.
116. Epstein JB, Chin EA, Jacobson JJ, Rishiraj B, Le N,. The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 286-292.
117. Papas A, Russell D, Singh M, Kent R, Triol C, Winston A,. Caries clinical trial of a remineralising toothpaste in radiation patients. Gerodontology. 2008; 25: 76-88.
118. Marques MA, Dib LL,. Periodontal changes in patients undergoing radiotherapy. J Periodontol. 2004; 75: 1178-1187.
119. Epstein JB, Lunn R, Le N, Stevenson-Moore P,. Periodontal attachment loss in patients after head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 673-677.
120. Friedman PK, Isfeld D,. Xerostomia: the "invisible" oral health condition. J Mass Dent Soc. 2008; 57: 42-44.
121. Nagler RM, Nagler A,. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant. 1999; 23: 1007-1011.
122. Carpenter PA, Schubert MM, Flowers ME,. Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2006; 12: 792-794.
123. Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH,. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94: 712-716.
124. Funk GF, Karnell LH, Christensen AJ,. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol. 2012; 138: 123-133.
125. Lang H, France E, Williams B, Humphris G, Wells M,. The psychological experience of living with head and neck cancer: a systematic review and meta-synthesis. Psychooncology. 2013; 22: 2648-2663.
126. Fingeret MC, Yuan Y, Urbauer D, Weston J, Nipomnick S, Weber R,. The nature and extent of body image concerns among surgically treated patients with head and neck cancer. Psychooncology. 2012; 21: 836-844.
127. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB,. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997; 12: 277-287.
128. Radloff LS,. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychological Meas. 1977; 1: 385-401.
129. Krebber AM, Buffart LM, Kleijn G, et al., Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014; 23: 121-130.
130. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-370.
131. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29.
132. Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2012, based on November 2014 SEER data submission. Bethesda, MD: National Cancer Institute; 2014. seer.cancer.gov/csr/1975-2012. Accessed January 27, 2016.
133. Simard S, Thewes B, Humphris G, et al., Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7: 300-322.
134. Boyes AW, Girgis A, Zucca AC, Lecathelinais C,. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey. Comment. Med J Aust. 2009; 191: 295.
135. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK,. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009; 169: 1274-1281.
136. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P,. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013; 14: 721-732.
137. Buchmann L, Conlee J, Hunt J, Agarwal J, White S,. Psychosocial distress is prevalent in head and neck cancer patients. Laryngoscope. 2013; 123: 1424-1429.
138. Posluszny DM, Dougall AL, Johnson JT, et al., Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partners. Head Neck. 2015; 37: 1282-1289.
139. Lydiatt WM, Moran J, Burke WJ,. A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol. 2009; 7: 397-403.
140. Devins GM, Payne AY, Lebel S, et al., The burden of stress in head and neck cancer. Psychooncology. 2013; 22: 668-676.
141. Chuang SC, Scelo G, Tonita JM, et al., Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008; 123: 2390-2396.
142. Kim SA, Roh JL, Lee SA, et al., Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer. 2016; 122: 131-140.
143. Rogers LQ, Courneya KS, Robbins KT, et al., Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer. 2006; 14: 1012-1019.
144. Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC,. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cohort. Head Neck. 2013; 35: 914-922.
145. Samuel SR, Maiya GA, Babu AS, Vidyasagar MS,. Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res. 2013; 137: 515-520.
146. McNeely ML, Parliament MB, Seikaly H, et al., Predictors of adherence to an exercise program for shoulder pain and dysfunction in head and neck cancer survivors. Support Care Cancer. 2012; 20: 515-522.
147. Ahmed AT, Karter AJ, Liu J,. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med. 2006; 23: 795-802.
148. Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC,. Alcohol and head and neck cancer risk in a prospective study. Br J Cancer. 2007; 96: 1469-1474.
149. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol drinking. IARC Monogr Eval Carcinog Risks Hum. 1988; 44: 1-378.
150. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum. 2010; 96: 3-1383.
151. Howren MB, Christensen AJ, Karnell LH, Funk GF,. Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol. 2013; 81: 299-317.
152. Siegel RL, Jacobs EJ, Newton CC, et al., Deaths due to cigarette smoking for 12 smoking-related cancers in the United States. JAMA. 2015; 175: 1574-1576.
153. Ostroff JS, Jacobsen PB, Moadel AB, et al., Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995; 75: 569-576.
154. Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC,. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991; 2: 105-112.
155. Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD,. Smoking cessation and lung cancer resection. Chest. 1996; 110: 1199-1202.
156. Davison AG, Duffy M,. Smoking habits of long-term survivors of surgery for lung cancer. Thorax. 1982; 37: 331-333.
157. Walker MS, Larsen RJ, Zona DM, Govindan R, Fisher EB,. Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study. Prev Med. 2004; 39: 449-457.
158. Parsons A, Daley A, Begh R, Aveyard P,. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis [serial online]. BMJ. 2010; 340: b5569.
159. Kawahara M, Ushijima S, Kamimori T, et al., Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; 78: 409-412.
160. Do KA, Johnson MM, Doherty DA, et al., Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003; 14: 131-138.
161. Browman GP, Wong G, Hodson I, et al., Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; 328: 159-163.
162. Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D,. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009; 40: 135-146.
163. Zevallos JP, Mallen MJ, Lam CY, et al., Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; 115: 4636-4644.
164. Arcavi L, Benowitz NL,. Cigarette smoking and infection. Arch Intern Med. 2004; 164: 2206-2216.
165. Moller AM, Pedersen T, Villebro N, Schnaberich A, Haas M, Tonnesen R,. A study of the impact of long-term tobacco smoking on postoperative intensive care admission. Anaesthesia. 2003; 58: 55-59.
166. Smith JB, Fenske NA,. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol. 1996; 34 (5 pt 1): 717-732; quiz 733-714.
167. Jerjes W, Upile T, Radhi H, et al., The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication [serial online]. Head Neck Oncol. 2012; 4: 6.
168. Berg CJ, Thomas AN, Mertens AC, et al., Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology. 2013; 22: 799-806.
169. Bloom EL, Oliver JA, Sutton SK, Brandon TH, Jacobsen PB, Simmons VN,. Post-operative smoking status in lung and head and neck cancer patients: association with depressive symptomatology, pain, and fatigue. Psychooncology. 2015; 24: 1012-1019.
170. Simmons VN, Litvin EB, Jacobsen PB, et al., Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013; 119: 1420-1427.
171. Nayan S, Gupta MK, Strychowsky JE, Sommer DD,. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013; 149: 200-211.
172. Mao JJ, Bowman MA, Stricker CT, et al., Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009; 27: 933-938.
173. Dawes AJ, Hemmelgarn M, Nguyen DK, et al., Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer. 2015; 121: 1249-1256.
174. Palmer SC, Stricker CT, Panzer SL, et al., Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Clin Oncol. 2015; 11: e222-e229.
175. Stricker CT, Jacobs LA, Risendal B, et al., Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011; 5: 358-370.
176. Kim Y, Kashy DA, Spillers RL, Evans TV,. Needs assessment of family caregivers of cancer survivors: three cohorts comparison. Psychooncology. 2010; 19: 573-582.
177. Given BA, Given CW, Sherwood PR,. Family and caregiver needs over the course of the cancer trajectory. J Support Oncol. 2012; 10: 57-64.
178. Daraei P, Moore CE,. Racial disparity among the head and neck cancer population. J Cancer Educ. 2015; 30: 546-551.
179. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2011 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2014. cdc.gov/uscs. Accessed January 27, 2016.
180. American Cancer Society. Cancer Facts & Figures for African Americans 2013-2014. Atlanta, GA: American Cancer Society; 2013.
181. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. SEER Cancer Statistics Review, 1975-2011. seer.cancer.gov/archive/csr/1975-2011/. Accessed January 27, 2016.
182. Mead H, Cartwright-Smith L, Jones K, Ramos C, Woods K, Siegel B,. Racial and Ethnic Disparities in US Health Care: A Chartbook. New York: The Commonwealth Fund; 2008.
183. Rereddy SK, Jordan DR, Moore CE,. Dying to be screened: exploring the unequal burden of head and neck cancer in health provider shortage areas. J Cancer Educ. 2015; 30: 490-496.
184. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012; 60: 1957-1968.